Cargando…
Fairer financing of vaccines in a world living with COVID-19
Autores principales: | Megiddo, Itamar, Nonvignon, Justice, Owusu, Richmond, Chalkidou, Kalipso, Colson, Abigail, Gad, Mohamed, Klepac, Petra, Ruiz, Francis, Morton, Alec |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365434/ https://www.ncbi.nlm.nih.gov/pubmed/32665376 http://dx.doi.org/10.1136/bmjgh-2020-002951 |
Ejemplares similares
-
Mind the costs, too: towards better cost-effectiveness analyses of PBF programmes
por: Chi, Y-Ling, et al.
Publicado: (2018) -
Optimal subscription models to pay for antibiotics
por: Barlow, Euan, et al.
Publicado: (2022) -
COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions
por: Tagoe, Eunice Twumwaa, et al.
Publicado: (2021) -
Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model
por: Megiddo, Itamar, et al.
Publicado: (2016) -
Application of decision analytical models to diabetes in low- and middle-income countries: a systematic review
por: Twumwaa, Tagoe Eunice, et al.
Publicado: (2022)